| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.78 | 0.001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |